Diabetes

Latest News


Latest Videos


More News

This week, the top managed care stories included the White House budget director hinting at mandatory drug rebates in Medicare; a global cyberattack locked physicians out of patient records; and the National Diabetes Prevention Program released promising data from the first 4 years.

Findings from real-world studies will help clinicians and other health stakeholders better understand the use of Toujeo compared with Lantus, particularly regarding treatment dosage patterns, for patients with type 2 diabetes, according to Liz Zhou, MD, director of evidence-based medicine at Sanofi Medical Affairs.